The flexi cap fund will invest across market capitalisation—large cap, mid cap and small cap, thus offering a large investment horizon to h...

In 2022, pharma funds lost 9.68%. All the schemes in this category delivered negative returns last year. The underperformance is in line wi...

Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an...

"Mirae Asset Hybrid Equity Fund has an envious track record in five years of its existence. The scheme has offered good five- year rolling ...

The list includes star fund managers, rising star fund managers, and regular chief investment officers of some fund houses. Some of them jo...

Pick your companies very prudently looking at the earnings growth visibility and the management quality.

Fund managers believe that share valuations of the pharma sector are cheap.

Mirae Asset Mutual Fund is launching a new sector scheme with a focus on healthcare and allied sectors.